Aegerion Pharmaceuticals, Inc.

Chiesi Farmaceutici S.p.A. is actively expanding its rare disease business in Japan through a subsidiary established there in 2022 and as part of the family-owned Italian firm's global push into this

Attorneys from the US Department of Justice and the Food and Drug Administration sought to ameliorate worries that medical product companies could be readily found in violation of compliance provision

Attorneys from the US Department of Justice and Food and Drug Administration sought to ameliorate worries that medical product companies could be readily found in violation of compliance provisions in

Will Lewis has led Bridgewater, NJ-based Insmed Incorporated to FDA approval of Arikayce (amikacin liposome inhalation suspension), the first and only medication approved by the FDA for the treatmen